Jubilant Ingrevia Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Chandan Sengar

Chief executive officer

₹32.7m

Total compensation

CEO salary percentage	n/a
CEO tenure	2yrs
CEO ownership	n/a
Management average tenure	no data
Board average tenure	3.3yrs

Recent management updates

Recent updates

Earnings Tell The Story For Jubilant Ingrevia Limited (NSE:JUBLINGREA) As Its Stock Soars 29%

Apr 13

Jubilant Ingrevia Limited Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

Feb 02

Investors Should Be Encouraged By Jubilant Ingrevia's (NSE:JUBLINGREA) Returns On Capital

Dec 14

Calculating The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Oct 07

Jubilant Ingrevia Limited Just Missed Revenue By 86%: Here's What Analysts Think Will Happen Next

May 22

CEO

Chandan Sengar (59 yo)

2yrs

Tenure

₹32,662,719

Compensation

Mr. Chandan Singh Sengar, BSc., MBA, serves as President of Life Science Chemicals at Jubilant Pharmova Limited (formerly known as Jubilant Life Sciences Limited). He serves as Whole-time Director and Co-C...

Board Members

Name	Position	Tenure	Compensation	Ownership
Chandan Sengar	Co-CEO & Whole-time Director	2yrs	₹32.66m	no data
Hari Bhartia	Co-Chairman & Whole-Time Director	3.3yrs	no data	0.31% ₹ 262.0m
Deepak Jain	CEO, MD & Director	less than a year	no data	no data
Shyam Sunder Bhartia	Co-Chairman	3.3yrs	no data	0.0031% ₹ 2.7m
Sushil Roongta	Independent Non-Executive Director	3.3yrs	₹1.85m	no data
Arun Seth	Independent Non-Executive Director	3.3yrs	₹1.59m	0.0013% ₹ 1.1m
Priyavrat Bhartia	Non-Executive Director	3.3yrs	no data	0.88% ₹ 747.4m
Pradeep Banerjee	Independent Non-Executive Director	3.3yrs	₹1.92m	0.00068% ₹ 579.1k
Arjun Bhartia	Non-Executive Director	3.1yrs	no data	no data
Ameeta Chatterjee	Independent Director	3.1yrs	₹1.87m	no data
Sudha Pillai	Independent Non-Executive Director	3.3yrs	₹1.67m	no data
Siraj Chaudhry	Independent Non-Executive Director	3.3yrs	₹1.86m	no data

3.3yrs

Average Tenure

62yo

Average Age

Experienced Board: JUBLINGREA's board of directors are considered experienced (3.3 years average tenure).

Jubilant Ingrevia Management

Management criteria checks 3/4

Key information

Recent management updates

Jubilant Ingrevia Limited Announces Change in Management

Jubilant Ingrevia Limited Approves Appointment of Deepak Jain as CEO, Effective October 1, 2023

Jubilant Ingrevia Limited Announces Co-Chief Executive Officer Changes

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Earnings Tell The Story For Jubilant Ingrevia Limited (NSE:JUBLINGREA) As Its Stock Soars 29%

Investor sentiment improves as stock rises 18%

Consensus EPS estimates fall by 12%

Upcoming dividend of ₹2.50 per share at 1.2% yield

Jubilant Ingrevia Limited Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

A Look At The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Jubilant Ingrevia Limited Approves Interim Dividend for the Financial Year 2023-24, Payable on or Before February 28, 2024

Jubilant Ingrevia Limited to Report Q3, 2024 Results on Jan 30, 2024

Second quarter 2024 earnings released: EPS: ₹3.64 (vs ₹5.31 in 2Q 2023)

Jubilant Ingrevia Limited Announces Change in Management

Returns At Jubilant Ingrevia (NSE:JUBLINGREA) Are On The Way Up

Jubilant Ingrevia Limited Approves Appointment of Deepak Jain as CEO, Effective October 1, 2023

Jubilant Ingrevia Limited to Report Q2, 2024 Results on Oct 26, 2023

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Jubilant Ingrevia Limited to Report Q1, 2024 Results on Jul 26, 2023

Market Cool On Jubilant Ingrevia Limited's (NSE:JUBLINGREA) Earnings

Price target decreased by 11% to ₹752

Jubilant Ingrevia Limited Announces Co-Chief Executive Officer Changes

Full year 2023 earnings: EPS and revenues miss analyst expectations

Jubilant Ingrevia Limited to Report Q4, 2023 Results on May 16, 2023

Upcoming dividend of ₹2.50 per share at 1.0% yield

Jubilant Ingrevia (NSE:JUBLINGREA) Is Due To Pay A Dividend Of ₹2.50

Third quarter 2023 earnings released: EPS: ₹5.75 (vs ₹4.31 in 3Q 2022)

Jubilant Ingrevia Limited Approves Interim Dividend for the Financial Year 2022-2023, payable on or before March 1, 2023

Jubilant Ingrevia Limited to Report Q3, 2023 Results on Jan 31, 2023

Investors Should Be Encouraged By Jubilant Ingrevia's (NSE:JUBLINGREA) Returns On Capital

High number of new and inexperienced directors

Second quarter 2023 earnings released: EPS: ₹5.31 (vs ₹4.31 in 2Q 2022)

Jubilant Ingrevia Limited to Report Q2, 2023 Results on Oct 20, 2022

Calculating The Fair Value Of Jubilant Ingrevia Limited (NSE:JUBLINGREA)

Jubilant Ingrevia Limited Declares Dividend for the Financial Year Ended March 31, 2022

Now 20% undervalued

Upcoming dividend of ₹2.50 per share

First quarter 2023 earnings released

Jubilant Ingrevia Limited Announces Final Dividend for the Financial Year Ended March 31, 2022, Will Be Paid/ Dispatched on or Before October 25, 2022

Jubilant Ingrevia Limited to Report Q1, 2023 Results on Aug 05, 2022

Investor sentiment improved over the past week

Jubilant Ingrevia Limited Just Missed Revenue By 86%: Here's What Analysts Think Will Happen Next

Jubilant Ingrevia Limited Recommends Final Dividend for the Year Ended March 31, 2022, Payable on or Before September 8, 2022

Price target increased to ₹893

High number of new and inexperienced directors

High number of new and inexperienced directors

Jubilant Ingrevia Limited Declares the Interim Dividend for the Financial Year 2021-22, Payable on or Before March 2, 2022

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age